The trademark TELIBSO was filed by BIOFARMA, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on September 9, 2021, and received one opposition filed on November 18, 2021 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 18, 2021
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).